Ilya O. Nagornov

Ilya O. Nagornov

Auto-generated profile, based on publicly available information

Ilya O. Nagornov

Bochkov Medical Genetic Research Center

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2023 in Consilium Medicum
Verified
Journal Article
Open access
PDF file
ESEkaterina S. Schelkanovtseva
Ekaterina S. Schelkanovtseva
OMOlga Iu. Mironova
Olga Iu. Mironova
KSKirill A. Solovev
Kirill A. Solovev
EBElizaveta A. Berestova
Elizaveta A. Berestova
ABAlexander A. Balakhonov
Alexander A. Balakhonov
БАБалахонов Александр Алексеевич
Балахонов Александр Алексеевич
Background. The identification of early predictors of poor outcomes of new coronavirus infection is necessary for optimizing patient management algorithms for hospitalized patients with COVID-19. Aim. To study the role of chitotriosidase activity as a marker of unfavorable outcomes in COVID-19 hospitalized patients. Materials and methods. The prospective observational single-center study included 347 patients with COVID-19 hospitalized in university clinic. In addition to the standard laboratory analysis (complete blood count, C-reactive protein, ferritin, creatinine, international normalized ratio, etc.) the blood serum chitotriosidase activity was determined at all the patients on admission. Primary endpoints were mortality from all causes and performing invasive ventilation (IV) and/or non-invasive ventilation (NIV). This study was approved by the Local Ethics Committee №12-21 (Clinical Trial Registry: NCT04752085). Results. A total of 347 patients were enrolled in this study (average age 66 years, females 182 52.5%), 30 patients (8.6%) died during the hospitalization, 39 (11.2%) performed IV or NIV. Along with age more than 65 (odds ratio OR 10.81, 95% confidence interval CI 2.6444.22) and Neutrophil-Lymphocyte Ratio higher than 7 (OR 15.89, 95% CI 3.0981.65) chitotriosidase activity higher than 170 ng/hr/ml (OR 4.23, 95% CI 1.4512.35) were independent predictors of mortality during hospitalization. Neutrophil-Lymphocyte Ratio higher than 5.6 (OR 11.22, 95% CI 2.3753,1) and сhitotriosidase activity higher than 151 ng/hr/ml (OR 3.17, 95% CI 1.317.67) have been evaluated as predictors of performing IV/NIV. Conclusion. Chitotriosidase level more than 151 nmol/h/mL could be considered as an early predictor of severity and poor prognosis in hospitalized patients with COVID-19.

16 May 2022
Verified
Conference Paper
Closed access
ESE. Schelkanovtseva
E. Schelkanovtseva
GIG. Isaev
G. Isaev
OMO. Mironova
O. Mironova
ASA. Skvortsov
A. Skvortsov
ASA. Suvorov
A. Suvorov
VFV. Fomin
V. Fomin

15 July 2021 in Russian Journal of Child Neurology
Verified
Journal Article
Open access
PDF file
ESE. V. Saifullina
E. V. Saifullina
EGE. V. Gaysina
E. V. Gaysina
RMR. V. Magzhanov
R. V. Magzhanov
AYA. A. Yalaev
A. A. Yalaev
INI. O. Nagornov
I. O. Nagornov
Leukoencephalopathy with vanishing white matter (VWM disease) is a progressive neurodegenerative disease with a specific magnetic resonance pattern characterized by diffuse lesions to the white matter and cystic degeneration. In this article, we report a case VWM disease in a boy with white matter lesions, in whom early onset and neurological symptoms suggested infantile form of the disease. The diagnosis was confirmed by the detection of biallelic mutations c.1688GA (p.Arg563Gln) and c.1309GA (p.Val437Met) in the EIF2B5 gene. The c.1309GA mutation (p.Val437Met) was detected for the first time; it caused the development of severe disease.

29 September 2023 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
ESEkaterina S. Schelkanovtseva
Ekaterina S. Schelkanovtseva
GIGeorgy O. Isaev
Georgy O. Isaev
OMOlga Yu. Mironova
Olga Yu. Mironova
ABAlexander A. Balakhonov
Alexander A. Balakhonov
ASAlexey V. Skvortsov
Alexey V. Skvortsov
СВСкворцов Алексей Вячеславович
Скворцов Алексей Вячеславович
Aim. To assess the relationship between plasma chitotiosidase (CHIT) level and mortality in hospitalized patients with COVID-19. Materials and methods. 347 hospitalized patients with COVID-19 were enrolled in our single-center cohort prospective observational study. On the first day of hospitalization the patients were assessed by the level of CHIT in the venosus blood to addition to default laboratory examinations. The primary endpoint was all-cause death. The survival after hospital discharge were assessed via phone calls on 90 and 180 days since inclusion to the study (NCT04752085). Results. Our study included 347 patients. The first symptoms appeared in 7 days [5; 7] before hospitalization; 283 (84.3%) patients had less than 50% of the involvement of the lung tissue to the inflammation process (CT 02); 36 (10.4%) patients had died since the start of our investigation; 30 (83.3%) of them died during hospitalization, others -no later than 60 days; 68 (19%) people didnt answer during phone call. The survivor's activity of the enzyme in the deceased was significantly lower in compare to deceased patients (90.5 [40.2; 178.0] nmol/h/mL vs 180.0 [77.2; 393.2] nmol/h/mL; p=0.001). Survivor of the patients with a higher level of the activity of the CHIT (more than 171 nmol/h/mL) was statically significantly lower. Conclusion. Rising of the CHIT's activity more than 171 nmol/h/mL might be an early independent predictor of the bad prognosis of the patients, who were hospitalized with COVID-19 infection.

31 August 2023 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
ESE. S. Shchelkanovtseva
E. S. Shchelkanovtseva
OMO. Yu. Mironova
O. Yu. Mironova
КСК. А. Соловьёв
К. А. Соловьёв
EBE. A. Berestova
E. A. Berestova
ABA. A. Balakhonov
A. A. Balakhonov
APA. S. Panferov
A. S. Panferov
Aim: To assess the relationship between initial plasma chitotriosidase (CHIT) activity and the dynamics of computed tomography (CT) data: lung injury volume, liver and spleen density in COVID-19 hospitalized patients.Material and Methods. The sub-analysis of the study registered in the Clinical Trial Registry with number: NCT04752085 was performed. The data of patients with available CT data of the chest on admission and at least once in dynamics during the period of hospitalization and the initial level of CTS in the blood plasma were analyzed. The density of the liver and spleen was determined in the scanned upper abdominal images, followed by the calculation of the ratio of the density of the liver to the density of the spleen.Results. A total of 121 patients were enrolled in this sub-analysis. Their baseline characteristics were as follows: median age 62 [53;70], males 48,7%. Between the day of admission and 7 [6;9] days of hospitalization, there was a significant increase in mean liver density from 52,04 [45,4; 56,7] to 57,5 [49,8; 62,7] HU and L/S ratio (liver to spleen ratio) 1,05 [0,91; 1,14] to 1,13 [0,99; 1,28], p < 0,001. The dynamics of the volume of lung tissue damage was multidirectional and, in general, did not change significantly. CHIT activity among patients whose lung injury volume increased during the hospitalization was significantly lower (65 [27; 119] nmol/ml/h) compared with patients whose lung injury volume did not change or decreased (124 [53; 232] nmol/ml/h), p = 0.006. The risk of lung injury progression was higher in patients with baseline CHIT level less than 100 nmol/h/ mL, (HR 3.1, 95% CI 1.4–6.9).Conclusion. Insufficient increase of CHIT activity can be associated with progression of lung injury, but does not affect the evolution of liver and spleen density as measured by CT.